Equities

Astena Holdings Co Ltd

8095:TYO

Astena Holdings Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)507.00
  • Today's Change-1.00 / -0.20%
  • Shares traded126.40k
  • 1 Year change-1.55%
  • Beta0.5872
Data delayed at least 20 minutes, as of Nov 13 2024 03:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Astena Holdings Co Ltd grew revenues 4.73% from 49.64bn to 51.98bn. In addition the company has reduced the cost of goods sold as a percent of sales, selling, general and administrative expenses as a percent of sales and interest paid as a percent of sales. These improvements contributed to 100.61% net income growth from 579.61m to 1.16bn.
Gross margin34.11%
Net profit margin3.91%
Operating margin3.56%
Return on assets3.12%
Return on equity7.45%
Return on investment5.76%
More ▼

Cash flow in JPYView more

In 2023, Astena Holdings Co Ltd did not generate a significant amount of cash. However, the company earned 1.65bn from its operations for a Cash Flow Margin of 3.17%. In addition the company generated 1.08bn cash from financing while 2.84bn was spent on investing.
Cash flow per share115.71
Price/Cash flow per share4.55
Book value per share721.11
Tangible book value per share549.19
More ▼

Balance sheet in JPYView more

Astena Holdings Co Ltd has a Debt to Total Capital ratio of 34.90%, a higher figure than the previous year's 16.97%.
Current ratio1.24
Quick ratio0.879
Total debt/total equity0.5391
Total debt/total capital0.349
More ▼

Growth rates in JPY

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items increased 102.40%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)3.46%
Div growth rate (5 year)11.38%
Payout ratio (TTM)34.90%
EPS growth(5 years)-7.60
EPS (TTM) vs
TTM 1 year ago
1,042.48
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.